Health
Q&A: Bristol-Myers’ top scientist on the future of cancer care
Dr. Thomas Lynch, famed for his role in a game-changing discovery in targeted cancer therapy, talked to STAT about why he joined Bristol-Myers.
"oncology"
Q&A: Bristol-Myers’ top scientist on the future of cancer care
Dr. Thomas Lynch, famed for his role in a game-changing discovery in targeted cancer therapy, talked to STAT about why he joined Bristol-Myers.
Health
Q&A: Repurposing existing drugs for new uses in cancer — for no profit
Dr. Vikas Sukhatme has plenty of ideas on how to improve cancer therapy. And they all revolve around repurposing inexpensive, generic drugs.
FDA warns against widely used ovarian cancer screening test
The FDA warned women and their doctors that current screening tests for ovarian cancer are unreliable, and could lead to false diagnoses.
Health
FDA warns against widely used ovarian cancer screening test
The FDA warned women and their doctors that current screening tests for ovarian cancer are unreliable, and could lead to false diagnoses.
Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer
A panel of top scientists is urging the creation of a new national network to allow cancer patients to have their tumors genetically profiled.
Health
Top scientists lay out sweeping recommendations for ‘moonshot’ against cancer
A panel of top scientists is urging the creation of a new national network to allow cancer patients to have their tumors genetically profiled.
Health
Most experts who develop cancer treatment guidelines have ties to industry
A study found that 86 percent of experts who serve on National Comprehensive Cancer Center panels held at least one financial conflict of interest in 2014.
